J&J bows out of RSV vaccine race after scrapping trial
Former FDA official says agency dysfunction led to baby formula crisis
FDA lifts partial hold on Blueprint's CDK2 inhibitor
Pressure is building on pharma and biotech companies to take climate action
*please scroll down for all the latest news*
